Feedback / Questions
AIC100 - AffyImmune Therap
https://www.prnewswire.com/news-releases/affyimmune-therapeutics-announces-ind-approval-for-a-first-in-man-trial-of-affinity-tuned-car-t-cells-for-patients-with-advanced-refractory-thyroid-cancer-300948315.html
Oct 30, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev